This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahuja, S. C.
Right arrow Articles by Marcove, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahuja, S. C.
Right arrow Articles by Marcove, R. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 59, Issue 5 632-647, Copyright © 1977 by Journal of Bone and Joint Surgery, Inc

JOURNAL CONTENTS

Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis

SC Ahuja, AB Villacin, J Smith, PG Bullough, AG Huvos and RC Marcove

In twenty-four cases of juxtacortical osteogenic sarcoma, three histological grades of malignancy were identified and correlated with the prognosis. The eighteen patients with Grade-I or II tumors had a significantly better prognosis than the six with Grade-III lesions. The three grades could not be distinguished roentgenographically. Grade I and II tumors, which showed a high cure rate after amputation, may be amenable to en block resection, provided the entire tumor can be removed with a good margin of uninvolved soft tissue and underlying bone. Grade-III tumors, on the other hand, had a poor prognosis despite early radical surgery.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
J. S. Wunder, N. Gokgoz, R. Parkes, S. B. Bull, S. Eskandarian, A. M. Davis, C. P. Beauchamp, E. U. Conrad, R. J. Grimer, J. H. Healey, et al.
TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
J. Clin. Oncol., March 1, 2005; 23(7): 1483 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. D. Murphey, J. S. Jelinek, H. T. Temple, D. J. Flemming, and F. H. Gannon
Imaging of Periosteal Osteosarcoma: Radiologic-Pathologic Comparison
Radiology, October 1, 2004; 233(1): 129 - 138.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
P O'Donnell and P O'Donnell
Evaluation of focal bone lesions: basic principles and clinical scenarios
Imaging, December 1, 2003; 15(4): 298 - 323.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
V. O. Lewis, M. C. Gebhardt, and D. S. Springfield
Parosteal Osteosarcoma of the Posterior Aspect of the Distal Part of the Femur : Oncological and Functional Results Following a New Resection Technique
J. Bone Joint Surg. Am., August 1, 2000; 82(8): 1083 - 1083.
[Abstract] [Full Text]